Grading the neuroendocrine tumors of the lung: An evidence-based proposal

Endocrine-Related Cancer

Volumn 21, Issue 1, 2014, Pages 1-16

  Rindi, G ^a   Klersy, C ^b   Inzani, F ^a   Fellegara, G ^c   Ampollini, L ^d   Ardizzoni, A ^e   Campanini, N ^e   Carbognani, P ^d   De Pas, T M ^f   Galetta, D ^f   Granone, P L ^a   Righi, L ^g   Rusca, M ^d   Spaggiari, L ^h   Tiseo, M ^e   Viale, G ^f   Volante, M ^g   Papotti, M ^g   Pelosi, G ^f,i,j  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c Centro Diagnostico Italiano   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

^e UNIVERSITY HOSPITAL OF PARMA   (Italy)

^f EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ UNIVERSITY OF MILAN   (Italy)

^j NATIONAL CANCER INSTITUTE   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER PATIENT; CANCER SURVIVAL; CARCINOID; EVIDENCE BASED PRACTICE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG NEUROENDOCRINE TUMOR; LUNG SMALL CELL CANCER; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROENDOCRINE TUMOR; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NEUROENDOCRINE; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; LONGITUDINAL STUDIES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84893538166     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0246     Document Type: Article

References (26)

1. Asamura H, Kameya T, Matsuno Y, Noguchi M, Tada H, Ishikawa Y, Yokose T, Jiang SX, Inoue T, Nakagawa K et al. 2006 Neuroendocrine neoplasms of the lung: a prognostic spectrum. Journal of Clinical Oncology 24 70-76. (doi:10.1200/JCO.2005.04.1202)
2. den Bakker MA, Willemsen S, Grunberg K, Noorduijn LA, van Oosterhout MF, van Suylen RJ, Timens W, Vrugt B, Wiersma-van Tilburg A & Thunnissen FB 2010 Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability. Histopathology 56 356-363. (doi:10.1111/j.1365-2559. 2010.03486.x)
3. Bosman F, Carneiro F, Hruban RH & Theise ND 2010 In WHO Classification of Tumours of the Digestive System. Lyon, France: IARC Press.
4. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL & Trotti A 2010 In AJCC Cancer Staging Manual. New York, NY, USA: Springer.
5. Grimaldi F, Muser D, Beltrami CA, Machin P, Morelli A, Pizzolitto S, Talmassons G, Marciello F, Colao AA, Monaco R et al. 2011 Partitioning of bronchopulmonary carcinoids in two different prognostic categories by ki-67 score. Frontiers in Endocrinology 2 20. (doi:10.3389/fendo.2011.00020)
6. Ha SY, Han J, Kim WS, Suh BS & Roh MS 2012 Interobserver variability in diagnosing high-grade neuroendocrine carcinoma of the lung and comparing it with the morphometric analysis. Korean Journal of Pathology 46 42-47. (doi:10.4132/KoreanJPathol.2012.46.1.42)
7. Harrell FE Jr, Lee KL & Mark DB 1996 Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine 15 361-387. (doi:10.1002/(SICI) 1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4)
8. Huang Q, Muzitansky A & Mark EJ 2002 Pulmonary neuroendocrine carcinomas. A review of 234 cases and a statistical analysis of 50 cases treated at one institution using a simple clinicopathologic classification. Archives of Pathology & Laboratory Medicine 126 545-553.
9. Iyoda A, Hiroshima K, Nakatani Y & Fujisawa T 2007 Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma. Annals of Thoracic Surgery 84 702-707. (doi:10.1016/j.athoracsur.2007.03.093)
10. Klimstra DS 2013 Pathology reporting of neuroendocrine tumors: essential elements for accurate diagnosis, classification, and staging. Seminars in Oncology 40 23-36. (doi:10.1053/j.seminoncol.2012.11.001)
11. Marchevsky AM, Gal AA, Shah S & Koss MN 2001 Morphometry confirms the presence of considerable nuclear size overlap between "small cells" and "large cells" in high-grade pulmonary neuroendocrine neoplasms. American Journal of Clinical Pathology 116 466-472. (doi:10.1309/H40B-8W14-4Q47- 03EP)
12. Newson RB 2010 Comparing the predictive powers of survival models using Harrell's C or Somers' D. Stata Journal 10 339-358.
13. Pelosi G, Rodriguez J, Viale G & Rosai J 2005 Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients. American Journal of Surgical Pathology 29 179-187. (doi:10.1097/01.pas.0000149690.75462. 29)
14. Righi L, Volante M, Tavaglione V, Bille A, Daniele L, Angusti T, Inzani F, Pelosi G, Rindi G & Papotti M 2010 Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases. Annals of Oncology 21 548-555. (doi:10.1093/annonc/mdp334)
15. Rindi G, Kloppel G, Couvelard A, Komminoth P, Korner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A et al. 2007 TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Archiv 451 757-762. (doi:10.1007/s00428-007-0452-1)
16. Rindi G, Arnold R, Capella C, Klimstra DS, Klöppel G, Komminoth P & Solcia E 2010 Nomenclature and classification of digestive neuroendocrine tumours. In World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Digestive System, pp 10-12. Eds F Bosman & F Carneiro. Lyon: IARC Press.
17. Rindi G, Falconi M, Klersy C, Albarello L, Boninsegna L, Buchler MW, Capella C, Caplin M, Couvelard A, Doglioni C et al. 2012 TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. Journal of the National Cancer Institute 104 764-777. (doi:10.1093/jnci/djs208)
18. Scarpa A, Mantovani W, Capelli P, Beghelli S, Boninsegna L, Bettini R, Panzuto F, Pederzoli P, delle Fave G & Falconi M 2010 Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Modern Pathology 23 824-833. (doi:10.1038/modpathol.2010.58)
19. Schneider CA, Rasband WS & Eliceiri KW 2012 NIH Image to ImageJ: 25 years of image analysis. Nature Methods 9 671-675. (doi:10.1038/nmeth.2089)
20. Tang LH, Gonen M, Hedvat C, Modlin IM & Klimstra DS 2012 Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods. American Journal of Surgical Pathology 36 1761-1770. (doi:10.1097/PAS.0b013e318263207c)
21. Travis WD, Gal AA, Colby TV, Klimstra DS, Falk R & Koss MN 1998 Reproducibility of neuroendocrine lung tumor classification. Human Pathology 29 272-279. (doi:10.1016/S0046-8177(98)90047-8)
22. Travis WD, Brambilla E, Müller-Hermelink HK & Harris CC Eds 2004 In World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press.
23. Travis WD, Giroux DJ, Chansky K, Crowley J, Asamura H, Brambilla E, Jett J, Kennedy C, Rami-Porta R, Rusch VW et al. 2008 The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer. Journal of Thoracic Oncology 3 1213-1223. (doi:10.1097/JTO.0b013e31818b06e3)
24. Walts AE, Ines D & Marchevsky AM 2012 Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors. Modern Pathology 25 1258-1264. (doi:10.1038/modpathol.2012.81)
25. Yang Z, Tang LH & Klimstra DS 2011 Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification. American Journal of Surgical Pathology 35 853-860. (doi:10.1097/PAS. 0b013e31821a0696)
26. Zahel T, Krysa S, Herpel E, Stenzinger A, Goeppert B, Schirmacher P, Hoffmann H, Schnabel PA & Warth A 2012 Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach. Virchows Archiv 460 299-308. (doi:10.1007/s00428-012-1194-2)